Molecular Profiling in Small Cell Lung Cancer

NCT03162705 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2019-01-22

No results posted yet for this study

Summary

This protocol is to obtain tumor tissues and blood samples from patients with a confirmed histological diagnosis of Small cell lung cancer(SCLC) for molecular profiling.

Conditions

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER
  • Sun Yat-sen University

    collaborator OTHER
  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Linlang Guo · ZhuJiang Hostipal

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-03
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162705 on ClinicalTrials.gov